For those of you that are on Keytruda (pembrolizumab), and met the mutation burden threshold after taking the Foundation One Test, are you technically on a "clincal trial" while being treated with Keytruda?
My mother is currently on Stivarga, which seems to be keeping most of the mets under control. But a new lymph node met popped up on a scan in july, and stivarga does not seem to work for that one node. The staff at our clinic hinted at clinical trials at UCSF, but didn't mention anything about Foundation One Test or Keytruda, as our onc is on vacation. We won't get the see the onc until late August.
I need some suggestions on what I will discuss with our onc at the next appointment. How do I go about mentioning to the onc about the Foundation One Test for mutation burden, if the onc himself does not suggesting trying Keytruda?
Meatie